Cargando…
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
BACKGROUND: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagictransformation is the greatest complication of this treatment, which may occur after recanalization of occludedartery. The aim of this study was to determine factors associated with clinical i...
Autores principales: | Mehrpour, Masoud, Aghaei, Mahboubeh, Motamed, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917484/ https://www.ncbi.nlm.nih.gov/pubmed/24791120 |
Ejemplares similares
-
Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013) -
Unusual Recovery of Aphasia in a Polyglot Iranian Patient after Ischemic Stroke
por: Mehrpour, Masoud, et al.
Publicado: (2014) -
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023) -
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative
por: Sasanejad, Payam, et al.
Publicado: (2021) -
Intravenous Thrombolysis for Acute Ischemic Stroke Due to Cardiac Myxoma
por: Esmaeili, Sara, et al.
Publicado: (2020)